Beyond Air Inc reports results for the quarter ended March 31 - Earnings Summary
Beyond Air Inc reports results for the quarter ended March 31 - Earnings Summary
Beyond Air Inc XAIR.OQ reported a quarterly adjusted loss of 63 cents per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-1.80. The mean expectation of three analysts for the quarter was for a loss of 57 cents per share. Wall Street expected results to range from -62 cents to -49 cents per share.
Revenue rose 65.5% to $1.91 million from a year ago; analysts expected $2.30 million.
Beyond Air Inc's reported EPS for the quarter was a loss of 77 cents.
The company reported a quarterly loss of $10.28 million.
Beyond Air Inc shares had fallen by 30.8% this quarter and lost 34.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 5.4% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Beyond Air Inc is $5.00, about 90.5% above its last closing price of $0.48
This summary was machine generated from LSEG data June 26 at 01:33 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Mar. 31 2026 | -0.57 | -0.63 | Missed |
Dec. 31 2025 | -0.82 | -0.83 | Missed |
Sep. 30 2025 | -0.85 | -1.25 | Missed |
Jun. 30 2025 | -1.40 | -1.53 | Missed |
Recent news on Beyond Air
See all newsBrief: Beyond Air Enters Definitive Agreement To Sell Its NeuroNOS Stake To UNIVO Pharmaceutical Industries In Exchange For Equity And Milestone Payments
Beyond Air Inc reports results for the quarter ended June 30 - Earnings Summary
Beyond Air Q1 net loss slightly widens, reaffirms 2026 outlook
Beyond Air Inc expected to post a loss of $10.80 a share - Earnings Preview
NASDAQ RESUMED AT 04:00 AM